Cargando…

Naloxone distribution and possession following a large‐scale naloxone programme

AIMS: To examine uptake following a large‐scale naloxone programme by estimating distribution rates since programme initiation and the proportion among a sample of high‐risk individuals who had attended naloxone training, currently possessed or had used naloxone. We also estimated the likelihood of...

Descripción completa

Detalles Bibliográficos
Autores principales: Madah‐Amiri, Desiree, Gjersing, Linn, Clausen, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585734/
https://www.ncbi.nlm.nih.gov/pubmed/30129078
http://dx.doi.org/10.1111/add.14425
_version_ 1783428761721503744
author Madah‐Amiri, Desiree
Gjersing, Linn
Clausen, Thomas
author_facet Madah‐Amiri, Desiree
Gjersing, Linn
Clausen, Thomas
author_sort Madah‐Amiri, Desiree
collection PubMed
description AIMS: To examine uptake following a large‐scale naloxone programme by estimating distribution rates since programme initiation and the proportion among a sample of high‐risk individuals who had attended naloxone training, currently possessed or had used naloxone. We also estimated the likelihood of naloxone possession and use as a function of programme duration, individual descriptive and substance use indicators. DESIGN: (1) Distribution data (June 2014–August 2017) and date of implementation for each city and (2) a cross‐sectional study among a sample of illicit substance users interviewed September 2017. SETTING: Seven Norwegian cities. PARTICIPANTS: A total of 497 recruited users of illegal opioids and/or central stimulants. MEASUREMENTS: Primary outcomes: naloxone possession and use. Random‐intercepts logistic regression models (covariates: male, age, homelessness/shelter use, overdose, incarceration, opioid maintenance treatment, income sources, substance use indicators, programme duration). FINDINGS: Overall, 4631 naloxone nasal sprays were distributed in the two pilot cities, with a cumulative rate of 495 per 100 000 population. In the same two cities, among high‐risk individuals, 44% and 62% reported current naloxone possession. The possession rates of naloxone corresponded well to the duration of each participating city's distribution programme. Overall, in the six distributing cities, 58% reported naloxone training, 43% current possession and 15% naloxone use. The significant indicators for possession were programme duration [adjusted odds ratios (aOR) = 1.44, 95% confidence interval (CI = 0.82–2.37], female gender (aOR = 1.97, 95% CI = 1.20–3.24) and drug‐dealing (aOR = 2.36, 95% CI = 1.42–3.93). The significant indicators for naloxone use were programme duration (aOR = 1.49 95%, CI = 1.15–1.92), homelessness/shelter use (aOR = 2.06, 95% CI = 1.02–4.17), opioid maintenance treatment (OMT) (aOR = 2.07, 95% CI = 1.13–3.78), drug‐dealing (aOR = 2.40, 95% CI = 1.27–4.54) and heroin injecting (aOR = 2.13, 95% CI = 1.04–4.38). CONCLUSIONS: A large‐scale naloxone programme in seven Norwegian cities with a cumulative distribution rate of 495 per 100 000 population indicated good saturation in a sample of high‐risk individuals, with programme duration in each city as an important indicator for naloxone possession and use.
format Online
Article
Text
id pubmed-6585734
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65857342019-06-27 Naloxone distribution and possession following a large‐scale naloxone programme Madah‐Amiri, Desiree Gjersing, Linn Clausen, Thomas Addiction Research Reports AIMS: To examine uptake following a large‐scale naloxone programme by estimating distribution rates since programme initiation and the proportion among a sample of high‐risk individuals who had attended naloxone training, currently possessed or had used naloxone. We also estimated the likelihood of naloxone possession and use as a function of programme duration, individual descriptive and substance use indicators. DESIGN: (1) Distribution data (June 2014–August 2017) and date of implementation for each city and (2) a cross‐sectional study among a sample of illicit substance users interviewed September 2017. SETTING: Seven Norwegian cities. PARTICIPANTS: A total of 497 recruited users of illegal opioids and/or central stimulants. MEASUREMENTS: Primary outcomes: naloxone possession and use. Random‐intercepts logistic regression models (covariates: male, age, homelessness/shelter use, overdose, incarceration, opioid maintenance treatment, income sources, substance use indicators, programme duration). FINDINGS: Overall, 4631 naloxone nasal sprays were distributed in the two pilot cities, with a cumulative rate of 495 per 100 000 population. In the same two cities, among high‐risk individuals, 44% and 62% reported current naloxone possession. The possession rates of naloxone corresponded well to the duration of each participating city's distribution programme. Overall, in the six distributing cities, 58% reported naloxone training, 43% current possession and 15% naloxone use. The significant indicators for possession were programme duration [adjusted odds ratios (aOR) = 1.44, 95% confidence interval (CI = 0.82–2.37], female gender (aOR = 1.97, 95% CI = 1.20–3.24) and drug‐dealing (aOR = 2.36, 95% CI = 1.42–3.93). The significant indicators for naloxone use were programme duration (aOR = 1.49 95%, CI = 1.15–1.92), homelessness/shelter use (aOR = 2.06, 95% CI = 1.02–4.17), opioid maintenance treatment (OMT) (aOR = 2.07, 95% CI = 1.13–3.78), drug‐dealing (aOR = 2.40, 95% CI = 1.27–4.54) and heroin injecting (aOR = 2.13, 95% CI = 1.04–4.38). CONCLUSIONS: A large‐scale naloxone programme in seven Norwegian cities with a cumulative distribution rate of 495 per 100 000 population indicated good saturation in a sample of high‐risk individuals, with programme duration in each city as an important indicator for naloxone possession and use. John Wiley and Sons Inc. 2018-09-14 2019-01 /pmc/articles/PMC6585734/ /pubmed/30129078 http://dx.doi.org/10.1111/add.14425 Text en © 2018 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Reports
Madah‐Amiri, Desiree
Gjersing, Linn
Clausen, Thomas
Naloxone distribution and possession following a large‐scale naloxone programme
title Naloxone distribution and possession following a large‐scale naloxone programme
title_full Naloxone distribution and possession following a large‐scale naloxone programme
title_fullStr Naloxone distribution and possession following a large‐scale naloxone programme
title_full_unstemmed Naloxone distribution and possession following a large‐scale naloxone programme
title_short Naloxone distribution and possession following a large‐scale naloxone programme
title_sort naloxone distribution and possession following a large‐scale naloxone programme
topic Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585734/
https://www.ncbi.nlm.nih.gov/pubmed/30129078
http://dx.doi.org/10.1111/add.14425
work_keys_str_mv AT madahamiridesiree naloxonedistributionandpossessionfollowingalargescalenaloxoneprogramme
AT gjersinglinn naloxonedistributionandpossessionfollowingalargescalenaloxoneprogramme
AT clausenthomas naloxonedistributionandpossessionfollowingalargescalenaloxoneprogramme